Renalytix plc
RNLXY· OTC
RNLXYRenalytix plc
Filed Nov 19, 2024 · 10-Q · 50 days after period end · 0000950170-24-128687
| Metric | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Revenue | $522.00K | $459.00K | $969.00K |
| Net Income | -$4.73M | -$10.15M | -$11.95M |
| EPS Diluted | -$0.04 | -$0.11 | -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Renalytix plc · CIK 1811115 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 19, 2024 · 50 d after period end
